Literature DB >> 15185860

What does pain or discomfort in irritable bowel syndrome mean?

Masanori Handa1, Hideyuki Nukina, Katsumi Ando, Chiharu Kubo.   

Abstract

Despite many studies on pain of functional gastrointestinal disorders (FGID), the pain mechanism of FGID is not well understood, and pain treatment of FGID is not established. Following our former functional dyspepsia (FD) study, we proposed two subgroups of patients with irritable bowel syndrome (IBS), pain and discomfort (not pain). The duration of disease of discomfort IBS patients was longer than that of pain IBS patients (P < 0.05) The rate of anxiety disorder of pain IBS patients tended to be higher than that of discomfort IBS patients (P = 0.07172). Fifteen (15.2%) of 99 pain IBS patients and 1 (3.4%) of 29 discomfort IBS patients overlapped FD (P < 0.1). We expected that a common psychosocial mechanism would influence both pain dyspepsia patients and pain IBS patients, however, there were some differences between these FGID patients with pain. Anxiety in IBS patients with lower gastrointestinal pain seems to be important in their treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15185860     DOI: 10.1023/b:ddas.0000026301.47638.92

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  22 in total

Review 1.  Psychosocial aspects of the functional gastrointestinal disorders.

Authors:  D A Drossman; F H Creed; K W Olden; J Svedlund; B B Toner; W E Whitehead
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Chronic functional abdominal pain.

Authors:  D A Drossman
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

3.  Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach.

Authors:  M Handa; K Mine; H Yamamoto; H Hayashi; O Tsuchida; F Kanazawa; C Kubo
Journal:  J Clin Gastroenterol       Date:  1999-04       Impact factor: 3.062

4.  Gastric hypersensitivity in nonulcer dyspepsia: an inconsistent finding.

Authors:  S Klatt; O Pieramico; C Guethner; B Glasbrenner; K Beckh; G Adler
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

5.  Psychiatric illness and contraction abnormalities of the esophagus.

Authors:  R E Clouse; P J Lustman
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

6.  Abnormal sensory perception in patients with esophageal chest pain.

Authors:  J E Richter; C F Barish; D O Castell
Journal:  Gastroenterology       Date:  1986-10       Impact factor: 22.682

7.  Low vagal activity as mediating mechanism for the relationship between personality factors and gastric symptoms in functional dyspepsia.

Authors:  T T Haug; S Svebak; T Hausken; I Wilhelmsen; A Berstad; H Ursin
Journal:  Psychosom Med       Date:  1994 May-Jun       Impact factor: 4.312

Review 8.  Sexual and physical abuse and gastrointestinal illness. Review and recommendations.

Authors:  D A Drossman; N J Talley; J Leserman; K W Olden; M A Barreiro
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

9.  Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone.

Authors:  M Bradette; P Pare; P Douville; A Morin
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

Review 10.  Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy.

Authors:  J E Richter; L A Bradley; D O Castell
Journal:  Ann Intern Med       Date:  1989-01-01       Impact factor: 25.391

View more
  3 in total

1.  Childhood physical abuse in outpatients with psychosomatic symptoms.

Authors:  Masanori Handa; Hideyuki Nukina; Masako Hosoi; Chiharu Kubo
Journal:  Biopsychosoc Med       Date:  2008-03-21

2.  Empathy and patient-physician conflicts.

Authors:  Jodi Halpern
Journal:  J Gen Intern Med       Date:  2007-05       Impact factor: 5.128

Review 3.  Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.

Authors:  Rachel D Moloney; Siobhain M O'Mahony; Timothy G Dinan; John F Cryan
Journal:  Front Psychiatry       Date:  2015-02-16       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.